Follow the people · Insider
Xiaodong Wang
Xiaodong Wang files insider transactions with the SEC as a director and other role of BeOne Medicines. We hold 1 disclosed purchase or sale filed since 18 November 2016, 1 of them in the last 90 days.
- Files for 2 companiesONC, BGNE
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure10 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 10 June 2025 — 8 September 2026Director and Other role · BeOne Medicines 27 Form 4 lines · source: SEC Form 4
- Filed 16 November 2016 — 13 May 2025Director and Other role · BeiGene 309 Form 4 lines · source: SEC Form 4
Every transaction
336 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 8 Sep 2026 | 10 Sep 2026SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 1,181 shares | down −1.4% | up +1.4% |
| 8 Sep 2026 | 10 Sep 2026SEC Form 4 | 2 d | exercised options overnot a trade | BeOne Medicinesderivative | 403,351 shares | down −1.4% | up +1.4% |
| 8 Sep 2026 | 10 Sep 2026SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 2,841 shares | down −1.4% | up +1.4% |
| 8 Sep 2026 | 10 Sep 2026SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 1,517 shares | down −1.4% | up +1.4% |
| 8 Sep 2026 | 10 Sep 2026SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 1,721 shares | down −1.4% | up +1.4% |
| 8 Sep 2026 | 10 Sep 2026SEC Form 4 | 2 d | exercised options overnot a trade | BeOne Medicines | 31,027 shares | down −1.4% | up +1.4% |
| 8 Sep 2026 | 10 Sep 2026SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 7,492 shares | down −1.4% | up +1.4% |
| 8 Sep 2026 | 10 Sep 2026SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 10,688 shares | down −1.4% | up +1.4% |
| 8 Sep 2026 | 10 Sep 2026SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 6,569 shares | down −1.4% | up +1.4% |
| 8 Sep 2026 | 10 Sep 2026SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 6,278 shares | down −1.4% | up +1.4% |
| 11 Jun 2026 | 15 Jun 2026SEC Form 4 | 4 d | was grantednot a trade | BeOne Medicines | 99,892 shares | up +33.1% | up +29.2% |
| 11 Jun 2026 | 15 Jun 2026SEC Form 4 | 4 d | was grantednot a trade | BeOne Medicinesderivative | 193,492 shares | up +33.1% | up +29.2% |
| 7 Nov 2025 | 12 Nov 2025SEC Form 4 | 5 d | gave awaynot a trade | BeOne Medicines | 424,073 shares | up +8.3% | down −8.2% |
| 9 Sep 2025 | 11 Sep 2025SEC Form 4 | 2 d | gave awaynot a trade | BeOne Medicines | 148,096 shares | down −1.3% | up +3.2% |
| 24 Jun 2025 | 25 Jun 2025SEC Form 4 | 1 d | sold on the open market | BeOne Medicines | 300 shares | up +29.9% | up +29.7% |
| 24 Jun 2025 | 25 Jun 2025SEC Form 4 | 1 d | sold on the open market | BeOne Medicines | 1,100 shares | up +29.9% | up +29.7% |
| 24 Jun 2025 | 25 Jun 2025SEC Form 4 | 1 d | sold on the open market | BeOne Medicines | 507 shares | up +29.9% | up +29.7% |
| 24 Jun 2025 | 25 Jun 2025SEC Form 4 | 1 d | sold on the open market | BeOne Medicines | 100 shares | up +29.9% | up +29.7% |
| 10 Jun 2025 | 12 Jun 2025SEC Form 4 | 2 d | was grantednot a trade | BeOne Medicinesderivative | 185,796 shares | up +31.5% | up +25.3% |
| 10 Jun 2025 | 12 Jun 2025SEC Form 4 | 2 d | exercised options overnot a trade | BeOne Medicinesderivative | 542,880 shares | up +31.5% | up +25.3% |
| 10 Jun 2025 | 12 Jun 2025SEC Form 4 | 2 d | was grantednot a trade | BeOne Medicines | 98,696 shares | up +31.5% | up +25.3% |
| 10 Jun 2025 | 12 Jun 2025SEC Form 4 | 2 d | exercised options overnot a trade | BeOne Medicines | 41,760 shares | up +31.5% | up +25.3% |
| 10 Jun 2025 | 12 Jun 2025SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 2,901 shares | up +31.5% | up +25.3% |
| 10 Jun 2025 | 12 Jun 2025SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 15,878 shares | up +31.5% | up +25.3% |
| 10 Jun 2025 | 12 Jun 2025SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 16,094 shares | up +31.5% | up +25.3% |
| 10 Jun 2025 | 12 Jun 2025SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 6,787 shares | up +31.5% | up +25.3% |
| 10 Jun 2025 | 12 Jun 2025SEC Form 4 | 2 d | sold on the open market | BeOne Medicines | 100 shares | up +31.5% | up +25.3% |
| 13 May 2025 | 15 May 2025SEC Form 4 | 2 d | exercised options overnot a trade | BeiGenederivative | 542,880 shares | up +54.2% | up +53.5% |
| 13 May 2025 | 15 May 2025SEC Form 4 | 2 d | exercised options overnot a trade | BeiGene | 41,760 shares | up +54.2% | up +53.5% |
| 13 May 2025 | 15 May 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 10,221 shares | up +54.2% | up +53.5% |
| 13 May 2025 | 15 May 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 21,235 shares | up +54.2% | up +53.5% |
| 13 May 2025 | 15 May 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 10,104 shares | up +54.2% | up +53.5% |
| 13 May 2025 | 15 May 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 200 shares | up +54.2% | up +53.5% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | exercised options overnot a trade | BeiGenederivative | 542,880 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | exercised options overnot a trade | BeiGene | 41,760 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 995 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 805 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,884 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 5,516 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,229 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 15,041 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 6,398 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,592 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,056 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,869 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,475 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 535 shares | up +42.7% | up +51.9% |
| 14 Apr 2025 | 16 Apr 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 365 shares | up +42.7% | up +51.9% |
| 18 Mar 2025 | 20 Mar 2025SEC Form 4 | 2 d | exercised options overnot a trade | BeiGenederivative | 542,880 shares | up +32.6% | up +32.0% |
| 18 Mar 2025 | 20 Mar 2025SEC Form 4 | 2 d | exercised options overnot a trade | BeiGene | 41,760 shares | up +32.6% | up +32.0% |
| 18 Mar 2025 | 20 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,417 shares | up +32.6% | up +32.0% |
| 18 Mar 2025 | 20 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 6,926 shares | up +32.6% | up +32.0% |
| 18 Mar 2025 | 20 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,694 shares | up +32.6% | up +32.0% |
| 18 Mar 2025 | 20 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 10,448 shares | up +32.6% | up +32.0% |
| 18 Mar 2025 | 20 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 11,245 shares | up +32.6% | up +32.0% |
| 18 Mar 2025 | 20 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 6,923 shares | up +32.6% | up +32.0% |
| 18 Mar 2025 | 20 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,107 shares | up +32.6% | up +32.0% |
| 11 Mar 2025 | 13 Mar 2025SEC Form 4 | 2 d | gave awaynot a trade | BeiGene | 158,717 shares | up +41.0% | up +36.1% |
| 4 Mar 2025 | 6 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 700 shares | up +34.7% | up +34.8% |
| 4 Mar 2025 | 6 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,000 shares | up +34.7% | up +34.8% |
| 4 Mar 2025 | 6 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 825 shares | up +34.7% | up +34.8% |
| 4 Mar 2025 | 6 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,275 shares | up +34.7% | up +34.8% |
| 4 Mar 2025 | 6 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,214 shares | up +34.7% | up +34.8% |
| 4 Mar 2025 | 6 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,809 shares | up +34.7% | up +34.8% |
| 4 Mar 2025 | 6 Mar 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 323 shares | up +34.7% | up +34.8% |
| 4 Feb 2025 | 6 Feb 2025SEC Form 4 | 2 d | exercised options overnot a trade | BeiGenederivative | 542,880 shares | up +55.4% | up +51.4% |
| 4 Feb 2025 | 6 Feb 2025SEC Form 4 | 2 d | exercised options overnot a trade | BeiGene | 41,760 shares | up +55.4% | up +51.4% |
| 4 Feb 2025 | 6 Feb 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 9,099 shares | up +55.4% | up +51.4% |
| 4 Feb 2025 | 6 Feb 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,519 shares | up +55.4% | up +51.4% |
| 4 Feb 2025 | 6 Feb 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,161 shares | up +55.4% | up +51.4% |
| 4 Feb 2025 | 6 Feb 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 17,805 shares | up +55.4% | up +51.4% |
| 4 Feb 2025 | 6 Feb 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 9,776 shares | up +55.4% | up +51.4% |
| 4 Feb 2025 | 6 Feb 2025SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,400 shares | up +55.4% | up +51.4% |
| 7 Jan 2025 | 8 Jan 2025SEC Form 4 | 1 d | exercised options overnot a trade | BeiGenederivative | 542,880 shares | up +97.9% | up +94.8% |
| 7 Jan 2025 | 8 Jan 2025SEC Form 4 | 1 d | exercised options overnot a trade | BeiGene | 41,760 shares | up +97.9% | up +94.8% |
| 7 Jan 2025 | 8 Jan 2025SEC Form 4 | 1 d | sold on the open market | BeiGene | 19,251 shares | up +97.9% | up +94.8% |
| 7 Jan 2025 | 8 Jan 2025SEC Form 4 | 1 d | sold on the open market | BeiGene | 11,310 shares | up +97.9% | up +94.8% |
| 7 Jan 2025 | 8 Jan 2025SEC Form 4 | 1 d | sold on the open market | BeiGene | 4,260 shares | up +97.9% | up +94.8% |
| 7 Jan 2025 | 8 Jan 2025SEC Form 4 | 1 d | sold on the open market | BeiGene | 5,638 shares | up +97.9% | up +94.8% |
| 7 Jan 2025 | 8 Jan 2025SEC Form 4 | 1 d | sold on the open market | BeiGene | 1,301 shares | up +97.9% | up +94.8% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | exercised options overnot a trade | BeiGenederivative | 542,880 shares | up +84.8% | up +92.2% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | exercised options overnot a trade | BeiGene | 41,760 shares | up +84.8% | up +92.2% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,600 shares | up +84.8% | up +92.2% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | sold on the open market | BeiGene | 7,063 shares | up +84.8% | up +92.2% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | sold on the open market | BeiGene | 9,956 shares | up +84.8% | up +92.2% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | sold on the open market | BeiGene | 9,266 shares | up +84.8% | up +92.2% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | sold on the open market | BeiGene | 6,350 shares | up +84.8% | up +92.2% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,300 shares | up +84.8% | up +92.2% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,833 shares | up +84.8% | up +92.2% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | sold on the open market | BeiGene | 993 shares | up +84.8% | up +92.2% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,374 shares | up +84.8% | up +92.2% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | sold on the open market | BeiGene | 725 shares | up +84.8% | up +92.2% |
| 10 Dec 2024 | 12 Dec 2024SEC Form 4 | 2 d | sold on the open market | BeiGene | 300 shares | up +84.8% | up +92.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | exercised options overnot a trade | BeiGenederivative | 499,993 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | exercised options overnot a trade | BeiGene | 38,461 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 4,425 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 300 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 5,875 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 400 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 2,700 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 200 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 6,187 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 700 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 12,293 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 407 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 6,981 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 1,014 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 1,186 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 600 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 1,475 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 2,725 shares | up +80.4% | up +61.2% |
| 26 Nov 2024 | 29 Nov 2024SEC Form 4 | 3 d | sold on the open market | BeiGene | 883 shares | up +80.4% | up +61.2% |
| 12 Aug 2024 | 14 Aug 2024SEC Form 4 | 2 d | gave awaynot a trade | BeiGene | 301,457 shares | up +82.3% | up +85.6% |
| 5 Jun 2024 | 7 Jun 2024SEC Form 4 | 2 d | was grantednot a trade | BeiGenederivative | 410,657 shares | up +117.9% | up +121.6% |
| 5 Jun 2024 | 7 Jun 2024SEC Form 4 | 2 d | was grantednot a trade | BeiGene | 108,992 shares | up +117.9% | up +121.6% |
| 30 Nov 2023 | 4 Dec 2023SEC Form 4 | 4 d | gave awaynot a trade | BeiGene | 71,890 shares | up +85.4% | up +91.3% |
| 30 Nov 2023 | 4 Dec 2023SEC Form 4 | 4 d | acquired or disposed of, othernot a trade | BeiGene | 172,372 shares | up +85.4% | up +91.3% |
| 15 Jun 2023 | 20 Jun 2023SEC Form 4 | 5 d | was grantednot a trade | BeiGenederivative | 327,249 shares | up +72.4% | up +80.9% |
| 15 Jun 2023 | 20 Jun 2023SEC Form 4 | 5 d | was grantednot a trade | BeiGene | 86,216 shares | up +72.4% | up +80.9% |
| 16 Mar 2023 | 20 Mar 2023SEC Form 4 | 4 d | gave awaynot a trade | BeiGene | 67,444 shares | up +54.2% | up +55.4% |
| 8 Mar 2023 | 10 Mar 2023SEC Form 4 | 2 d | exercised options overnot a trade | BeiGenederivative | 879,255 shares | up +52.2% | up +60.2% |
| 8 Mar 2023 | 10 Mar 2023SEC Form 4 | 2 d | exercised options overnot a trade | BeiGene | 67,635 shares | up +52.2% | up +60.2% |
| 8 Mar 2023 | 10 Mar 2023SEC Form 4 | 2 d | sold on the open market | BeiGene | 3,433 shares | up +52.2% | up +60.2% |
| 8 Mar 2023 | 10 Mar 2023SEC Form 4 | 2 d | sold on the open market | BeiGene | 7,458 shares | up +52.2% | up +60.2% |
| 8 Mar 2023 | 10 Mar 2023SEC Form 4 | 2 d | sold on the open market | BeiGene | 12,534 shares | up +52.2% | up +60.2% |
| 8 Mar 2023 | 10 Mar 2023SEC Form 4 | 2 d | sold on the open market | BeiGene | 400 shares | up +52.2% | up +60.2% |
| 8 Mar 2023 | 10 Mar 2023SEC Form 4 | 2 d | sold on the open market | BeiGene | 200 shares | up +52.2% | up +60.2% |
| 8 Mar 2023 | 10 Mar 2023SEC Form 4 | 2 d | sold on the open market | BeiGene | 14,077 shares | up +52.2% | up +60.2% |
| 8 Mar 2023 | 10 Mar 2023SEC Form 4 | 2 d | sold on the open market | BeiGene | 17,170 shares | up +52.2% | up +60.2% |
| 8 Mar 2023 | 10 Mar 2023SEC Form 4 | 2 d | sold on the open market | BeiGene | 12,363 shares | up +52.2% | up +60.2% |
| 12 Jan 2023 | 17 Jan 2023SEC Form 4 | 5 d | sold on the open market | BeiGene | 4,099 shares | up +31.6% | up +29.4% |
| 12 Jan 2023 | 17 Jan 2023SEC Form 4 | 5 d | sold on the open market | BeiGene | 901 shares | up +31.6% | up +29.4% |
| 11 Jan 2023 | 11 Jan 2023SEC Form 4 | 0 d | sold on the open market | BeiGene | 200 shares | up +36.2% | up +36.2% |
| 11 Jan 2023 | 11 Jan 2023SEC Form 4 | 0 d | sold on the open market | BeiGene | 1,250 shares | up +36.2% | up +36.2% |
| 11 Jan 2023 | 11 Jan 2023SEC Form 4 | 0 d | sold on the open market | BeiGene | 950 shares | up +36.2% | up +36.2% |
| 11 Jan 2023 | 11 Jan 2023SEC Form 4 | 0 d | sold on the open market | BeiGene | 100 shares | up +36.2% | up +36.2% |
| 10 Jan 2023 | 11 Jan 2023SEC Form 4 | 1 d | sold on the open market | BeiGene | 1,600 shares | up +38.6% | up +36.2% |
| 9 Jan 2023 | 11 Jan 2023SEC Form 4 | 2 d | sold on the open market | BeiGene | 900 shares | up +40.9% | up +36.2% |
| 13 Dec 2022 | 15 Dec 2022SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,392 shares | up +66.5% | up +66.7% |
| 13 Dec 2022 | 15 Dec 2022SEC Form 4 | 2 d | sold on the open market | BeiGene | 956 shares | up +66.5% | up +66.7% |
| 13 Dec 2022 | 15 Dec 2022SEC Form 4 | 2 d | sold on the open market | BeiGene | 665 shares | up +66.5% | up +66.7% |
| 28 Nov 2022 | 30 Nov 2022SEC Form 4 | 2 d | gave awaynot a trade | BeiGene | 52,000 shares | up +93.3% | up +80.8% |
| 15 Nov 2022 | 17 Nov 2022SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,987 shares | up +66.8% | up +72.8% |
| 6 Sep 2022 | 8 Sep 2022SEC Form 4 | 2 d | gave awaynot a trade | BeiGene | 33,410 shares | up +112.0% | up +107.2% |
| 8 Aug 2022 | 9 Aug 2022SEC Form 4 | 1 d | sold on the open market | BeiGene | 2,974 shares | up +71.3% | up +75.3% |
| 8 Aug 2022 | 9 Aug 2022SEC Form 4 | 1 d | sold on the open market | BeiGene | 1,824 shares | up +71.3% | up +75.3% |
| 8 Aug 2022 | 9 Aug 2022SEC Form 4 | 1 d | sold on the open market | BeiGene | 100 shares | up +71.3% | up +75.3% |
| 8 Aug 2022 | 9 Aug 2022SEC Form 4 | 1 d | sold on the open market | BeiGene | 1,060 shares | up +71.3% | up +75.3% |
| 8 Aug 2022 | 9 Aug 2022SEC Form 4 | 1 d | sold on the open market | BeiGene | 102 shares | up +71.3% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 300 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 200 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 100 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 100 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 2,100 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 600 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 1,000 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 400 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 100 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 100 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 300 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 200 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 100 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 100 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 888 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 1,644 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 968 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 600 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 100 shares | up +78.2% | up +75.3% |
| 5 Aug 2022 | 9 Aug 2022SEC Form 4 | 4 d | sold on the open market | BeiGene | 100 shares | up +78.2% | up +75.3% |
| 22 Jun 2022 | 24 Jun 2022SEC Form 4 | 2 d | was grantednot a trade | BeiGenederivative | 471,913 shares | up +122.6% | up +94.7% |
| 22 Jun 2022 | 24 Jun 2022SEC Form 4 | 2 d | was grantednot a trade | BeiGene | 83,499 shares | up +122.6% | up +94.7% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 300 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 200 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 300 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 775 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 440 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 662 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 38 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 300 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 200 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 677 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 308 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 100 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 200 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 400 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 100 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 300 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 700 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 402 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 700 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 98 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 300 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 200 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 500 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 300 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 200 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 100 shares | down −1.0% | down −5.8% |
| 8 Nov 2021 | 10 Nov 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 200 shares | down −1.0% | down −5.8% |
| 1 Jul 2021 | 1 Jul 2021SEC Form 4 | 0 d | sold on the open market | BeiGene | 300 shares | down −0.9% | down −0.9% |
| 1 Jul 2021 | 1 Jul 2021SEC Form 4 | 0 d | sold on the open market | BeiGene | 437 shares | down −0.9% | down −0.9% |
| 1 Jul 2021 | 1 Jul 2021SEC Form 4 | 0 d | sold on the open market | BeiGene | 1,100 shares | down −0.9% | down −0.9% |
| 1 Jul 2021 | 1 Jul 2021SEC Form 4 | 0 d | sold on the open market | BeiGene | 1,500 shares | down −0.9% | down −0.9% |
| 1 Jul 2021 | 1 Jul 2021SEC Form 4 | 0 d | sold on the open market | BeiGene | 1,211 shares | down −0.9% | down −0.9% |
| 1 Jul 2021 | 1 Jul 2021SEC Form 4 | 0 d | sold on the open market | BeiGene | 300 shares | down −0.9% | down −0.9% |
| 16 Jun 2021 | 21 Jun 2021SEC Form 4 | 5 d | was grantednot a trade | BeiGenederivative | 241,839 shares | up +4.0% | up +6.4% |
| 16 Jun 2021 | 21 Jun 2021SEC Form 4 | 5 d | was grantednot a trade | BeiGene | 39,000 shares | up +4.0% | up +6.4% |
| 10 May 2021 | 12 May 2021SEC Form 4 | 2 d | exercised options overnot a trade | BeiGenederivative | 88,231 shares | up +14.2% | up +10.8% |
| 10 May 2021 | 12 May 2021SEC Form 4 | 2 d | exercised options overnot a trade | BeiGene | 44,109 shares | up +14.2% | up +10.8% |
| 10 May 2021 | 12 May 2021SEC Form 4 | 2 d | exercised options overnot a trade | BeiGene | 3,394 shares | up +14.2% | up +10.8% |
| 10 May 2021 | 12 May 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,100 shares | up +14.2% | up +10.8% |
| 10 May 2021 | 12 May 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,594 shares | up +14.2% | up +10.8% |
| 10 May 2021 | 12 May 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 311 shares | up +14.2% | up +10.8% |
| 10 May 2021 | 12 May 2021SEC Form 4 | 2 d | sold on the open market | BeiGene | 389 shares | up +14.2% | up +10.8% |
| 15 Dec 2020 | 17 Dec 2020SEC Form 4 | 2 d | gave awaynot a trade | BeiGene | 165,295 shares | up +44.8% | up +33.0% |
| 10 Dec 2020 | 14 Dec 2020SEC Form 4 | 4 d | gave awaynot a trade | BeiGene | 88,010 shares | up +52.0% | up +51.9% |
| 10 Dec 2020 | 14 Dec 2020SEC Form 4 | 4 d | gave awaynot a trade | BeiGene | 1,244,542 shares | up +52.0% | up +51.9% |
| 10 Dec 2020 | 14 Dec 2020SEC Form 4 | 4 d | gave awaynot a trade | BeiGene | 1,244,542 shares | up +52.0% | up +51.9% |
| 16 Oct 2020 | 20 Oct 2020SEC Form 4 | 4 d | sold on the open market | BeiGene | 5,000 shares | up +9.4% | up +15.5% |
| 5 Oct 2020 | 7 Oct 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 5,000 shares | up +13.2% | up +16.5% |
| 25 Sep 2020 | 29 Sep 2020SEC Form 4 | 4 d | sold on the open market | BeiGene | 4,380 shares | up +22.7% | up +23.1% |
| 25 Sep 2020 | 29 Sep 2020SEC Form 4 | 4 d | sold on the open market | BeiGene | 620 shares | up +22.7% | up +23.1% |
| 17 Sep 2020 | 21 Sep 2020SEC Form 4 | 4 d | sold on the open market | BeiGene | 4,916 shares | up +31.9% | up +27.8% |
| 17 Sep 2020 | 21 Sep 2020SEC Form 4 | 4 d | sold on the open market | BeiGene | 84 shares | up +31.9% | up +27.8% |
| 11 Aug 2020 | 12 Aug 2020SEC Form 4 | 1 d | gave awaynot a trade | BeiGene | 1,560 shares | up +65.4% | up +62.5% |
| 10 Aug 2020 | 12 Aug 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,500 shares | up +65.5% | up +62.5% |
| 10 Aug 2020 | 12 Aug 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,194 shares | up +65.5% | up +62.5% |
| 10 Aug 2020 | 12 Aug 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 100 shares | up +65.5% | up +62.5% |
| 10 Aug 2020 | 12 Aug 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 400 shares | up +65.5% | up +62.5% |
| 10 Aug 2020 | 12 Aug 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 400 shares | up +65.5% | up +62.5% |
| 10 Aug 2020 | 12 Aug 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 406 shares | up +65.5% | up +62.5% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 300 shares | up +36.4% | up +46.9% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,000 shares | up +36.4% | up +46.9% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 687 shares | up +36.4% | up +46.9% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,902 shares | up +36.4% | up +46.9% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,111 shares | up +36.4% | up +46.9% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 500 shares | up +36.4% | up +46.9% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 5,430 shares | up +36.4% | up +46.9% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,652 shares | up +36.4% | up +46.9% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,039 shares | up +36.4% | up +46.9% |
| 20 Jul 2020 | 22 Jul 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,379 shares | up +36.4% | up +46.9% |
| 7 Jul 2020 | 9 Jul 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 6,000 shares | up +76.3% | up +73.4% |
| 1 Jul 2020 | 6 Jul 2020SEC Form 4 | 5 d | sold on the open market | BeiGene | 690 shares | up +83.2% | up +76.1% |
| 1 Jul 2020 | 6 Jul 2020SEC Form 4 | 5 d | sold on the open market | BeiGene | 2,100 shares | up +83.2% | up +76.1% |
| 1 Jul 2020 | 6 Jul 2020SEC Form 4 | 5 d | sold on the open market | BeiGene | 1,600 shares | up +83.2% | up +76.1% |
| 1 Jul 2020 | 6 Jul 2020SEC Form 4 | 5 d | sold on the open market | BeiGene | 457 shares | up +83.2% | up +76.1% |
| 23 Jun 2020 | 24 Jun 2020SEC Form 4 | 1 d | sold on the open market | BeiGene | 1,845 shares | up +84.9% | up +86.1% |
| 23 Jun 2020 | 24 Jun 2020SEC Form 4 | 1 d | sold on the open market | BeiGene | 3,455 shares | up +84.9% | up +86.1% |
| 23 Jun 2020 | 24 Jun 2020SEC Form 4 | 1 d | sold on the open market | BeiGene | 700 shares | up +84.9% | up +86.1% |
| 22 Jun 2020 | 24 Jun 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,800 shares | up +88.9% | up +86.1% |
| 22 Jun 2020 | 24 Jun 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,220 shares | up +88.9% | up +86.1% |
| 22 Jun 2020 | 24 Jun 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 800 shares | up +88.9% | up +86.1% |
| 22 Jun 2020 | 24 Jun 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 180 shares | up +88.9% | up +86.1% |
| 17 Jun 2020 | 19 Jun 2020SEC Form 4 | 2 d | was grantednot a trade | BeiGenederivative | 560,599 shares | up +98.7% | up +89.7% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 3,500 shares | up +100.4% | up +101.6% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,300 shares | up +100.4% | up +101.6% |
| 8 Jun 2020 | 10 Jun 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 200 shares | up +100.4% | up +101.6% |
| 4 Mar 2020 | 6 Mar 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 3,031 shares | up +119.5% | up +126.0% |
| 4 Mar 2020 | 6 Mar 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,768 shares | up +119.5% | up +126.0% |
| 4 Mar 2020 | 6 Mar 2020SEC Form 4 | 2 d | sold on the open market | BeiGene | 201 shares | up +119.5% | up +126.0% |
| 15 Nov 2019 | 18 Nov 2019SEC Form 4 | 3 d | sold on the open market | BeiGene | 1,496 shares | up +74.8% | up +76.8% |
| 15 Nov 2019 | 18 Nov 2019SEC Form 4 | 3 d | sold on the open market | BeiGene | 395 shares | up +74.8% | up +76.8% |
| 14 Nov 2019 | 18 Nov 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 800 shares | up +76.4% | up +76.8% |
| 14 Nov 2019 | 18 Nov 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 2,500 shares | up +76.4% | up +76.8% |
| 14 Nov 2019 | 18 Nov 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 2,200 shares | up +76.4% | up +76.8% |
| 14 Nov 2019 | 18 Nov 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 704 shares | up +76.4% | up +76.8% |
| 14 Nov 2019 | 18 Nov 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 1,900 shares | up +76.4% | up +76.8% |
| 14 Nov 2019 | 18 Nov 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 300 shares | up +76.4% | up +76.8% |
| 14 Nov 2019 | 18 Nov 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 100 shares | up +76.4% | up +76.8% |
| 14 Nov 2019 | 18 Nov 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 2,605 shares | up +76.4% | up +76.8% |
| 13 Nov 2019 | 18 Nov 2019SEC Form 4 | 5 d | acquired or disposed of, othernot a trade | BeiGene | 50 shares | up +75.6% | up +76.8% |
| 13 Nov 2019 | 18 Nov 2019SEC Form 4 | 5 d | was grantednot a trade | BeiGene | 50 shares | up +75.6% | up +76.8% |
| 4 Nov 2019 | 5 Nov 2019SEC Form 4 | 1 d | sold on the open market | BeiGene | 1,000 shares | up +81.2% | up +82.3% |
| 1 Nov 2019 | 5 Nov 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 1,000 shares | up +82.8% | up +82.3% |
| 1 Jul 2019 | 1 Jul 2019SEC Form 4 | 0 d | sold on the open market | BeiGene | 2,200 shares | up +172.8% | up +172.8% |
| 1 Jul 2019 | 1 Jul 2019SEC Form 4 | 0 d | sold on the open market | BeiGene | 2,647 shares | up +172.8% | up +172.8% |
| 5 Jun 2019 | 7 Jun 2019SEC Form 4 | 2 d | was grantednot a trade | BeiGenederivative | 747,708 shares | up +188.9% | up +182.9% |
| 13 Mar 2019 | 14 Mar 2019SEC Form 4 | 1 d | gave awaynot a trade | BeiGene | 18,577 shares | up +153.8% | up +157.1% |
| 13 Mar 2019 | 14 Mar 2019SEC Form 4 | 1 d | gave awaynot a trade | BeiGene | 2,392 shares | up +153.8% | up +157.1% |
| 1 Mar 2019 | 5 Mar 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 1,300 shares | up +129.0% | up +131.7% |
| 1 Mar 2019 | 5 Mar 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 100 shares | up +129.0% | up +131.7% |
| 1 Mar 2019 | 5 Mar 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 200 shares | up +129.0% | up +131.7% |
| 1 Mar 2019 | 5 Mar 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 200 shares | up +129.0% | up +131.7% |
| 1 Mar 2019 | 5 Mar 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 200 shares | up +129.0% | up +131.7% |
| 1 Mar 2019 | 5 Mar 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 1,000 shares | up +129.0% | up +131.7% |
| 1 Mar 2019 | 5 Mar 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 600 shares | up +129.0% | up +131.7% |
| 1 Mar 2019 | 5 Mar 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 200 shares | up +129.0% | up +131.7% |
| 1 Mar 2019 | 5 Mar 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 200 shares | up +129.0% | up +131.7% |
| 1 Mar 2019 | 5 Mar 2019SEC Form 4 | 4 d | sold on the open market | BeiGene | 1,000 shares | up +129.0% | up +131.7% |
| 3 Dec 2018 | 4 Dec 2018SEC Form 4 | 1 d | sold on the open market | BeiGene | 2,671 shares | up +129.8% | up +135.5% |
| 3 Dec 2018 | 4 Dec 2018SEC Form 4 | 1 d | sold on the open market | BeiGene | 800 shares | up +129.8% | up +135.5% |
| 3 Dec 2018 | 4 Dec 2018SEC Form 4 | 1 d | sold on the open market | BeiGene | 529 shares | up +129.8% | up +135.5% |
| 3 Dec 2018 | 4 Dec 2018SEC Form 4 | 1 d | sold on the open market | BeiGene | 400 shares | up +129.8% | up +135.5% |
| 3 Dec 2018 | 4 Dec 2018SEC Form 4 | 1 d | sold on the open market | BeiGene | 300 shares | up +129.8% | up +135.5% |
| 3 Dec 2018 | 4 Dec 2018SEC Form 4 | 1 d | sold on the open market | BeiGene | 100 shares | up +129.8% | up +135.5% |
| 3 Dec 2018 | 4 Dec 2018SEC Form 4 | 1 d | sold on the open market | BeiGene | 100 shares | up +129.8% | up +135.5% |
| 3 Dec 2018 | 4 Dec 2018SEC Form 4 | 1 d | sold on the open market | BeiGene | 100 shares | up +129.8% | up +135.5% |
| 27 Nov 2018 | 28 Nov 2018SEC Form 4 | 1 d | gave awaynot a trade | BeiGene | 89,999 shares | up +137.4% | up +131.8% |
| 19 Nov 2018 | 21 Nov 2018SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,100 shares | up +178.7% | up +167.8% |
| 19 Nov 2018 | 21 Nov 2018SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,277 shares | up +178.7% | up +167.8% |
| 19 Nov 2018 | 21 Nov 2018SEC Form 4 | 2 d | sold on the open market | BeiGene | 1,173 shares | up +178.7% | up +167.8% |
| 19 Nov 2018 | 21 Nov 2018SEC Form 4 | 2 d | sold on the open market | BeiGene | 850 shares | up +178.7% | up +167.8% |
| 19 Nov 2018 | 21 Nov 2018SEC Form 4 | 2 d | sold on the open market | BeiGene | 600 shares | up +178.7% | up +167.8% |
| 13 Aug 2018 | 15 Aug 2018SEC Form 4 | 2 d | sold on the open market | BeiGene | 2,200 shares | up +117.9% | up +119.8% |
| 13 Aug 2018 | 15 Aug 2018SEC Form 4 | 2 d | sold on the open market | BeiGene | 700 shares | up +117.9% | up +119.8% |
| 13 Aug 2018 | 15 Aug 2018SEC Form 4 | 2 d | sold on the open market | BeiGene | 549 shares | up +117.9% | up +119.8% |
| 26 Jun 2018 | 28 Jun 2018SEC Form 4 | 2 d | was grantednot a trade | BeiGene | 94,133 shares | up +116.0% | up +124.1% |
| 26 Jun 2018 | 28 Jun 2018SEC Form 4 | 2 d | was grantednot a trade | BeiGenederivative | 655,044 shares | up +116.0% | up +124.1% |
| 8 Jun 2018 | 28 Jun 2018SEC Form 4 | 20 d | gave awaynot a trade | BeiGene | 5,000,000 shares | up +59.9% | up +124.1% |
| 22 Dec 2017 | 13 Feb 2018SEC Form 4 | 53 d | gave awaynot a trade | BeiGene | 36,400 shares | up +245.4% | up +183.8% |
| 27 Sep 2017 | 2 Oct 2017SEC Form 4 | 5 d | was grantednot a trade | BeiGene | 410,000 shares | up +246.4% | up +238.4% |
| 27 Sep 2017 | 2 Oct 2017SEC Form 4 | 5 d | was grantednot a trade | BeiGenederivative | 750,000 shares | up +246.4% | up +238.4% |
| 12 Jul 2017 | 13 Jul 2017SEC Form 4 | 1 d | sold on the open market | BeiGene | 3,700 shares | up +375.6% | up +378.9% |
| 12 Jul 2017 | 13 Jul 2017SEC Form 4 | 1 d | sold on the open market | BeiGene | 15,501 shares | up +375.6% | up +378.9% |
| 12 Jul 2017 | 13 Jul 2017SEC Form 4 | 1 d | sold on the open market | BeiGene | 799 shares | up +375.6% | up +378.9% |
| 28 Jun 2017 | 30 Jun 2017SEC Form 4 | 2 d | sold on the open market | BeiGene | 28,400 shares | up +661.4% | up +670.0% |
| 28 Jun 2017 | 30 Jun 2017SEC Form 4 | 2 d | sold on the open market | BeiGene | 6,600 shares | up +661.4% | up +670.0% |
| 2 Jun 2017 | 6 Jun 2017SEC Form 4 | 4 d | sold on the open market | BeiGene | 5,539 shares | up +744.9% | up +783.5% |
| 11 May 2017 | 6 Jun 2017SEC Form 4 | 26 d | gave awaynot a trade | BeiGene | 19,682 shares | up +837.8% | up +783.5% |
| 11 May 2017 | 6 Jun 2017SEC Form 4 | 26 d | gave awaynot a trade | BeiGene | 9,841 shares | up +837.8% | up +783.5% |
| 4 May 2017 | 5 May 2017SEC Form 4 | 1 d | sold on the open market | BeiGene | 4,491 shares | up +771.7% | up +781.7% |
| 3 May 2017 | 5 May 2017SEC Form 4 | 2 d | sold on the open market | BeiGene | 9,970 shares | up +753.1% | up +781.7% |
| 5 Apr 2017 | 7 Apr 2017SEC Form 4 | 2 d | sold on the open market | BeiGene | 5,456 shares | up +849.9% | up +831.0% |
| 5 Apr 2017 | 7 Apr 2017SEC Form 4 | 2 d | sold on the open market | BeiGene | 6,194 shares | up +849.9% | up +831.0% |
| 24 Mar 2017 | 24 Mar 2017SEC Form 4 | 0 d | sold on the open market | BeiGene | 18,587 shares | up +854.6% | up +854.6% |
| 24 Mar 2017 | 24 Mar 2017SEC Form 4 | 0 d | sold on the open market | BeiGene | 200 shares | up +854.6% | up +854.6% |
| 23 Mar 2017 | 24 Mar 2017SEC Form 4 | 1 d | sold on the open market | BeiGene | 11,041 shares | up +841.1% | up +854.6% |
| 22 Mar 2017 | 24 Mar 2017SEC Form 4 | 2 d | sold on the open market | BeiGene | 8,279 shares | up +811.9% | up +854.6% |
| 10 Mar 2017 | 10 Mar 2017SEC Form 4 | 0 d | sold on the open market | BeiGene | 7,304 shares | up +766.5% | up +766.5% |
| 9 Mar 2017 | 10 Mar 2017SEC Form 4 | 1 d | sold on the open market | BeiGene | 18,596 shares | up +774.1% | up +766.5% |
| 8 Mar 2017 | 10 Mar 2017SEC Form 4 | 2 d | sold on the open market | BeiGene | 10,992 shares | up +768.9% | up +766.5% |
| 27 Feb 2017 | 27 Feb 2017SEC Form 4 | 0 d | sold on the open market | BeiGene | 4,444 shares | up +810.4% | up +810.4% |
| 24 Feb 2017 | 27 Feb 2017SEC Form 4 | 3 d | sold on the open market | BeiGene | 27,902 shares | up +798.4% | up +810.4% |
| 24 Feb 2017 | 27 Feb 2017SEC Form 4 | 3 d | sold on the open market | BeiGene | 500 shares | up +798.4% | up +810.4% |
| 23 Feb 2017 | 27 Feb 2017SEC Form 4 | 4 d | sold on the open market | BeiGene | 5,505 shares | up +814.0% | up +810.4% |
| 23 Nov 2016 | 28 Nov 2016SEC Form 4 | 5 d | sold on the open market | BeiGene | 93,750 shares | up +982.8% | up +1022.1% |
| 16 Nov 2016 | 18 Nov 2016SEC Form 4 | 2 d | was grantednot a trade | BeiGenederivative | 1,613,430 shares | up +839.1% | up +982.8% |
Both percentages are the stock’s move, not Xiaodong Wang’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 336 of the 336 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.